Charles Schwab’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Buy |
1,042,450
+119,708
| +13% | +$1.39M | ﹤0.01% | 1915 |
|
|
2025
Q1 | $6.86M | Sell |
922,742
-33,832
| -4% | -$251K | ﹤0.01% | 2137 |
|
|
2024
Q4 | $5.73M | Buy |
956,574
+39,831
| +4% | +$239K | ﹤0.01% | 2278 |
|
|
2024
Q3 | $4.69M | Buy |
916,743
+10,262
| +1% | +$52.5K | ﹤0.01% | 2405 |
|
|
2024
Q2 | $3.28M | Buy |
906,481
+36,699
| +4% | +$133K | ﹤0.01% | 2530 |
|
|
2024
Q1 | $2.79M | Buy |
869,782
+113,850
| +15% | +$365K | ﹤0.01% | 2500 |
|
|
2023
Q4 | $3.7M | Sell |
755,932
-103,135
| -12% | -$505K | ﹤0.01% | 2428 |
|
|
2023
Q3 | $4.68M | Buy |
859,067
+21,177
| +3% | +$115K | ﹤0.01% | 2290 |
|
|
2023
Q2 | $5.62M | Buy |
837,890
+14,571
| +2% | +$97.8K | ﹤0.01% | 2197 |
|
|
2023
Q1 | $7.27M | Sell |
823,319
-1,080
| -0.1% | -$9.54K | ﹤0.01% | 2026 |
|
|
2022
Q4 | $6.3M | Buy |
824,399
+26,052
| +3% | +$199K | ﹤0.01% | 2092 |
|
|
2022
Q3 | $5.69M | Sell |
798,347
-295,271
| -27% | -$2.1M | ﹤0.01% | 2147 |
|
|
2022
Q2 | $8.85M | Buy |
1,093,618
+233,850
| +27% | +$1.89M | ﹤0.01% | 1905 |
|
|
2022
Q1 | $11.9M | Buy |
859,768
+19,097
| +2% | +$265K | ﹤0.01% | 1848 |
|
|
2021
Q4 | $23.6M | Buy |
840,671
+19,051
| +2% | +$535K | 0.01% | 1451 |
|
|
2021
Q3 | $27.9M | Buy |
821,620
+195,751
| +31% | +$6.65M | 0.01% | 1292 |
|
|
2021
Q2 | $25.6M | Buy |
625,869
+22,562
| +4% | +$922K | 0.01% | 1387 |
|
|
2021
Q1 | $24.3M | Buy |
603,307
+51,881
| +9% | +$2.09M | 0.01% | 1378 |
|
|
2020
Q4 | $32.6M | Buy |
551,426
+10,575
| +2% | +$625K | 0.01% | 1043 |
|
|
2020
Q3 | $26.3M | Buy |
540,851
+382,289
| +241% | +$18.6M | 0.01% | 1029 |
|
|
2020
Q2 | $7.67M | Buy |
158,562
+12,206
| +8% | +$591K | ﹤0.01% | 1798 |
|
|
2020
Q1 | $4.07M | Buy |
146,356
+54,460
| +59% | +$1.51M | ﹤0.01% | 1930 |
|
|
2019
Q4 | $2.75M | Buy |
91,896
+1,795
| +2% | +$53.7K | ﹤0.01% | 2314 |
|
|
2019
Q3 | $2.79M | Buy |
+90,101
| New | +$2.79M | ﹤0.01% | 2260 |
|